(AZN) AstraZeneca - Performance 15.5% in 12m
Compare AZN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
63.26%
#24 in Group
Rel. Strength 12m
73.09%
#2109 in Universe
Total Return 12m
15.51%
#51 in Group
Total Return 5y
127.08%
#26 in Group
12m Total Return: AZN (15.5%) vs XLV (-0.2%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group (based on Performance, Valuations and Relative Strength)
| Symbol | 1m | 12m | 5y | P/E | P/B | Growth Rating |
|---|---|---|---|---|---|---|
| CPH TO Cipher Pharmaceuticals |
-10.0% | 64.3% | 2,190% | 12.88 | 1.97 | 90.78 |
| PBH NYSE Prestige Brand Holdings |
-3.33% | 10.3% | 174% | 20.90 | 2.41 | 88.57 |
| NVS NYSE Novartis |
4.95% | 14.2% | 93.1% | 19.67 | 5.18 | 68.05 |
| NOVN SW Novartis |
2.68% | 15.2% | 77.9% | 19.33 | 5.01 | 65.13 |
| SUPN NASDAQ Supernus Pharmaceuticals |
-21.2% | -10.1% | 107% | 24.33 | 1.73 | 61.02 |
Performance Duell AZN vs XLV
| Total Return (including Dividends) | AZN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 4.21% | -1.75% | -9.56% |
| 3 Months | 16.52% | 2.48% | -8.43% |
| 12 Months | 15.51% | -0.24% | 8.24% |
| 5 Years | 127.08% | 90.57% | 147.98% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #37 | 6.06% | 15.2% |
| 3 Month | #29 | 13.7% | 27.3% |
| 12 Month | #51 | 15.8% | 6.71% |
| 5 Years | #28 | 19.2% | -8.42% |
| Trend Score (consistency of price movement) | AZN | XLV | S&P 500 |
| 1 Month | 77.9% | 24.5% | -95.3% |
| 3 Months | 90.8% | 82.3% | -17.6% |
| 12 Months | -18.5% | 23.5% | 91.5% |
| 5 Years | 90.1% | 90.5% | 84.5% |
FAQs
Does AZN AstraZeneca outperforms the market?
Yes,
over the last 12 months AZN made 15.51%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.24%.
Over the last 3 months AZN made 16.52%, while XLV made 2.48%.
Over the last 3 months AZN made 16.52%, while XLV made 2.48%.
Performance Comparison AZN vs Indeces and Sectors
AZN vs. Indices AZN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.48% | 13.8% | 0.37% | 7.27% |
| US NASDAQ 100 | QQQ | 2.83% | 16.8% | 0.30% | 8.50% |
| US Dow Jones Industrial 30 | DIA | 2.78% | 12.7% | -0.25% | 9.27% |
| German DAX 40 | DAX | 2.15% | 4.48% | -21.4% | -9.31% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.10% | 3.16% | -22.1% | 4.81% |
| Hongkong Hang Seng | HSI | -0.31% | -3.75% | -17.1% | 3.01% |
| India NIFTY 50 | INDA | -0.36% | 7.94% | 14.7% | 18.6% |
| Brasil Bovespa | EWZ | -2.18% | 6.80% | 11.6% | 33.5% |
AZN vs. Sectors AZN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.59% | 13.6% | -10.7% | -3.93% |
| Consumer Discretionary | XLY | 5.29% | 19.4% | -1.34% | 8.21% |
| Consumer Staples | XLP | 2.71% | 6.78% | 3.38% | 8.41% |
| Energy | XLE | -2.66% | 7.03% | -4.44% | 15.8% |
| Financial | XLF | 2.73% | 12.5% | -8.26% | -1.51% |
| Health Care | XLV | 2.40% | 5.96% | 6.25% | 15.8% |
| Industrial | XLI | 1.71% | 10.8% | -0.33% | 8.85% |
| Materials | XLB | 1.85% | 10.1% | 6.67% | 20.8% |
| Real Estate | XLRE | 2.48% | 7.93% | 7.58% | 9.28% |
| Technology | XLK | 2.36% | 17.4% | 4.59% | 15.4% |
| Utilities | XLU | -3.19% | 6.82% | -0.87% | -9.44% |
| Aerospace & Defense | XAR | 0.02% | 10.9% | -5.08% | 0.40% |
| Biotech | XBI | 0.01% | 9.50% | 14.2% | 26.9% |
| Homebuilder | XHB | 4.62% | 14.1% | 19.0% | 25.6% |
| Retail | XRT | 4.86% | 20.4% | 10.1% | 26.4% |